New combo therapy aims to shrink abdominal tumors in colorectal cancer patients
NCT ID NCT07268677
First seen Jan 11, 2026 · Last updated May 13, 2026 · Updated 15 times
Summary
This study tests whether adding two drugs (pirfenidone and sintilimab) to standard chemotherapy can shrink tumors in people with colorectal cancer that has spread to the lining of the abdomen. About 30 adults aged 18 to 75 will receive the treatment for 4 cycles, then doctors will check if the tumors have shrunk. The goal is to see if this combination works better than chemotherapy alone.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.